Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1756 | 2019 |
SARS-CoV-2 variants B. 1.351 and P. 1 escape from neutralizing antibodies M Hoffmann, P Arora, R Groß, A Seidel, BF Hörnich, AS Hahn, N Krüger, ... Cell 184 (9), 2384-2393. e12, 2021 | 969 | 2021 |
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic M Hoffmann, N Krüger, S Schulz, A Cossmann, C Rocha, A Kempf, ... Cell 185 (3), 447-456. e11, 2022 | 873 | 2022 |
Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition S Meister, U Schubert, K Neubert, K Herrmann, R Burger, M Gramatzki, ... Cancer research 67 (4), 1783-1792, 2007 | 511 | 2007 |
Serum microRNAs as powerful cancer biomarkers J Wittmann, HM Jäck Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1806 (2), 200-207, 2010 | 335 | 2010 |
hUPF2 silencing identifies physiologic substrates of mammalian nonsense-mediated mRNA decay J Wittmann, EM Hol, HM Jäck Molecular and cellular biology 26 (4), 1272-1287, 2006 | 290 | 2006 |
SARS-CoV-2 variant B. 1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination M Hoffmann, H Hofmann-Winkler, N Krüger, A Kempf, I Nehlmeier, ... Cell reports 36 (3), 2021 | 261 | 2021 |
CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells. TM Ellis, PE Simms, DJ Slivnick, HM Jäck, RI Fisher Journal of immunology (Baltimore, Md.: 1950) 151 (5), 2380-2389, 1993 | 245 | 1993 |
IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. AH Rowley, CA Eckerley, HM Jäck, ST Shulman, SC Baker Journal of immunology (Baltimore, Md.: 1950) 159 (12), 5946-5955, 1997 | 243 | 1997 |
Cloning and characterization of HUPF1, a human homolog of the Saccharomyces cerevisiae nonsense mRNA-reducing UPF1 protein SE Applequist, M Selg, C Raman, HM Jäck Nucleic acids research 25 (4), 814-821, 1997 | 212 | 1997 |
Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production K Siemasko, ASF Chong, HM Jäck, H Gong, JW Williams, A Finnegan The Journal of Immunology 160 (4), 1581-1588, 1998 | 209 | 1998 |
Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance G Cattoretti, R Shaknovich, PM Smith, HM Jäck, VV Murty, B Alobeid The Journal of Immunology 177 (10), 6930-6939, 2006 | 170 | 2006 |
Pre–B cell receptor–mediated cell cycle arrest in Philadelphia chromosome–positive acute lymphoblastic leukemia requires IKAROS function D Trageser, I Iacobucci, R Nahar, C Duy, G von Levetzow, L Klemm, ... Journal of Experimental Medicine 206 (8), 1739-1753, 2009 | 152 | 2009 |
Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor J Hess, A Werner, T Wirth, F Melchers, HM Jäck, TH Winkler Proceedings of the National Academy of Sciences 98 (4), 1745-1750, 2001 | 151 | 2001 |
CD30 defines a subset of activated human T cells that produce IFN-gamma and IL-5 and exhibit enhanced B cell helper activity. M Alzona, HM Jäck, RI Fisher, TM Ellis Journal of immunology (Baltimore, Md.: 1950) 153 (7), 2861-2867, 1994 | 149 | 1994 |
Expression of BLIMP1/PRMT5and concurrent histone H2A/H4 arginine 3 dimethylation in fetal germ cells, CIS/IGCNU and germ cell tumors D Eckert, K Biermann, D Nettersheim, AJM Gillis, K Steger, HM Jäck, ... BMC developmental biology 8, 1-11, 2008 | 144 | 2008 |
BCL6 is critical for the development of a diverse primary B cell repertoire C Duy, JJ Yu, R Nahar, S Swaminathan, SM Kweon, JM Polo, E Valls, ... Journal of Experimental Medicine 207 (6), 1209-1221, 2010 | 143 | 2010 |
Surrogate light chain-dependent selection of Ig heavy chain V regions. U Keyna, GB Beck-Engeser, J Jongstra, SE Applequist, HM Jäck Journal of immunology (Baltimore, Md.: 1950) 155 (12), 5536-5542, 1995 | 138 | 1995 |
Interaction of murine precursor B cell receptor with stroma cells is controlled by the unique tail of λ5 and stroma cell-associated heparan sulfate H Bradl, J Wittmann, D Milius, C Vettermann, HM Jäck The Journal of Immunology 171 (5), 2338-2348, 2003 | 135 | 2003 |
Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional μ heavy chains GH Kline, L Hartwell, GB Beck-Engeser, U Keyna, S Zaharevitz, ... The Journal of Immunology 161 (4), 1608-1618, 1998 | 135 | 1998 |